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Results: There was no statistical difference between two groups in terms of demo-
graphic characteristicts even the age was higher in C-shape (Table 1). In C-shape
patients, the frequency of proximal and mid region lesions were found more than
distal lesions (p¼0.014) but there was no differences in S-shape patients. TFC in
patient group with S-shape were signiﬁcantly higher than patient group with C shape
when both groups were compared in terms of TFCs. The two groups lesion regions
were compared each other and there were no difference between vascular diameters.
Conclusıons: The frequency of lesion was higher in the proximal and mid sections of
C shape RCA. TFCs were signiﬁcantly higher in patients with S-shape group than
patients C shape group when they were compared in terms of TFCs.Demographics Parameters
C-shape (n¼124) S-shape (n¼39) P count
Age (years) 66,1512,28 59,9810,82 0,003
Diabetesmellitus 31(% 25) 12(% 30,8) 0,476
Hyperlipidemia 29(% 23,4) 8(% 20,5) 0,709
Smoking 34(% 27,4) 12(% 30,8) 0,685
The comparison of baseline characteristics of the patient groups.
Variables
GFRlowgroup (n ¼
205)
GFRhighgroup (n
¼ 206) P value
DM, n (%) 120 (58.5%) 34 (16.5%) <0.001
HT, n (%) 117 (57.1%) 78 (37.9%) <0.001
Creatinine (mg/dl) 1.050.21 0.720.13 <0.001
SYNTAX Score 17.99.7 8.25.1 <0.001
AD 2.01.1 2.81.6 <0.001
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Background: Postdilatation after stent implantation in stable patients has been re-
commended to achieve better angiographic results, but its effect in primary percuta-
neous coronary intervention (PCI) is less clear.
Objective: Our objective was to determine whether postdilatation has an effect on
clinical outcomes in STEMI. Our objective was to determine whether postdilatation
has an effect on clinical outcomes in STEMI.
Methods: This study was a single-center retrospective, observational study including
patients who presented with STEMI and were treated with primary PCI between
January 2008 and March 2013. Patients with STEMI who were treated with primary
PCI were included. Patients with non-ST-elevation myocardial infarction, bypass graft
occlusion, or who were not treated with primary PCI were excluded. The patients were
divided into two groups: 1) patients who did not undergo postdilatation after stent
implantation (Group 1) and 2) patients who underwent postdilatation (Group 2). The
patient demographics, risk factors, clinical presentation, procedural properties, and
major adverse cardiac events (MACE), including target lesion revascularization, target
vessel failure, and cardiac death at the hospital or during follow-up, were compared
between the two groups.
Conclusıon: In total, 227 patients underwent primary PCI for STEMI and were treated
with at least one stent. A total of 218 patients were included (Group 1¼ 57, Group
2 ¼161). The follow-up time was 79.68 58.89 weeks in Group 1 and 141.30 
87.07 weeks in Group 2 (p<0.001). The patient demographics, risk factors, clinical
presentation and procedural properties were all similar except for the increased use of
predilatation (75.4% vs. 94.4%, p<0.001) and intracoronary nitroglycerine in Group 2
(50.9% vs. 71.4%, p<0.05). The mean ﬁnal TIMI coronary ﬂow was better in Group 1
(2.89  0.31 vs. 2.61  0.66, p<0.05). The MACE rate both in hospital and during
follow-up did not differ between Groups 1 and 2.
Conclusion: Although stent postdilatation is negatively correlated with the ﬁnal TIMI
ﬂow grade, it does not appear to be correlated with worse long-term clinical outcomes.
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Impaired Kidney Function Associated with Both Syntax Score and Aortic
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Hakan Uçar, Mustafa Gür, Taner S¸eker, Durmus¸ Yıldıray S¸ahin, Gökhan Gözübüyük,
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Background: The strong relationships between severe renal dysfunction with coro-
nary artery disease (CAD) and arterial stiffness are well known. However, the asso-
ciations between the kidney function with SYNTAX Score and aortic distensibility
(AD) were not investigated in patients with stable CAD with normal to mildly
impaired renal function. We aimed to investigate the association between kidney
function with SYNTAX score and AD.
Methods: In this study, 411 stable CAD patients in whom coronary angiography was
performed were prospectively included (247 male, 164 female; mean age 58.612.4
years). GFR was estimated (eGFR) by the Modiﬁcation of Diet in Renal Disease
formula. Two different groups were determined according to median eGFR values
(GFRlow group <100.6, and GRFhigh group 100.6). Coronary angiography was
performed based on clinical indications. SS was determined in all patients. AD was
calculated from the echocardiographicallyJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTResults: Patients with GFRlow group were older, and have a history of hypertension
and diabetes mellitus and high BMI. SS and AD values of GFRlow group were
higher than GFRhigh group (p<0.001 for all). Multivariate regression analysis
showed that eGFR was independently associated with diabetes (b;-0.206, p<0.001),
hypertension (b;-0.093, p¼0.026), SS (b;-0.445, p<0.001) and AD (b;-0.096,
p¼0.019).
Conclusıon: Estimated GFR is independently associated with extent and complexity
of CAD and AD as well as frequencies of diabetes and hypertension. Importantly,
these results may explain, in part, the increase in cardiovascular risk in with slightly
impaired renal function.PP-365
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Aım: The platelet to lymphocyte ratio (PLR) has been shown as a predictor in
patients with malignancies but little is known about the association between PLR
and adverse events in the setting of acute ST-segment elevation myocardial
infarction (STEMI) treated with primary percutaneous intervention (PCI). Thus, we
sought to assess the predictive value of pre-procedural PLR on the development of
no-reﬂow in patients undergoing coronary stent implantation for the treatment of
STEMI.
Methods: Thrombolysis In Myocardial Infarction (TIMI) ﬂow grades of 287 patients
with STEMI treated with primary PCI were assessed. No-reﬂow was deﬁned as TIMI
Grade 2 ﬂows and angiographic success was deﬁned as TIMI 3 ﬂow.
Results: Patients were divided into 3 tertiles based upon pre-procedural PLR. No-
reﬂow developed in 6,14 and 43 patients in lower, middle and higher tertiles,
respectively (p< 0.001). Pre-procedural PLR was signiﬁcantly correlated with the
neutrophil/lymphocyte ratio (NLR) and age (r:0.697, p<0.001 and r:0.191,
p¼0.001;respectively). After regression analysis, pre-procedural PLR remained as
a signiﬁcant predictor of stent thrombosis (OR: 1.010, 95% conﬁdence interval: 1.004-
1.017, p¼0.001) together with pre-procedural NLR (OR: 1.200, 95% conﬁdence
interval: 1.059-1.360, p¼0.004). In receiver operating characteristics analysis, the
PLR> 160 had 75% sensitivity and 74% speciﬁcity and the NLR> 5.9 had 71%
sensitivity and 70% speciﬁcity in predicting no-reﬂow.
Conclusıon: High pre-procedural PLR is a signiﬁcant and independent predictor of
no-reﬂow in patients with acute STEMI undergoing primary PCI.ERS C225
Clinical, hematological and angiographic characteristics of the patients
according to pre-procedural platelet to lymphocyte ratio tertiles
Variable
Tertile 1
88.2 (84.6-91.8)
n¼96
Tertile 2
135.2 (132.0-
138.4)
n¼96
Tertile 3
231.7 (220.5-
242.8) p value
Age,years 57.6  13.3 60.2  13.7 64.5  13.2 0.002
Male sex, n (%) 78 (81.3) 70 (72.9) 65 (68.4) 0.120
Hypertension, n (%) 29 (30.2) 29 (30.2) 40 (42.1) 0.135
Diabetes mellitus, n (%) 13 (13.5) 25 (26) 24 (25.3) 0.062
Smoking, n (%) 51 (53.1) 55 (57.3) 35 (36.8) 0.012
Glucose, mg/dl 151  72 151  63 170  80 0.051
Creatinine, mg/dl 0.88  0.20 0.83  0.20 0.89  0.27 0.109
C-reactive protein*, mg/dl 0.65  0.38 0.67  0.43 0.78  0.54 0.573
Total cholesterol, mg/dl 175  42 175  36 168  40 0.339
High-density lipoprotein, mg/dl 37  9 34  8 35  11 0.828
Low-density lipoprotein, mg/dl 106  32 110  32 108  30 0.648
Triglyceride, mg/dl 152  111 150  89 133  78 0.388
Hemoglobin, g/dl 14.1  1.4 14.1  1.4 13.8  1.5 0.305
Red-cell distribution width, % 15.9  1.3 15.9  1.3 16.1  1.2 0.084
Platelet count, x 109/L 233  59 254  46 294  68 <0.001
Mean platelet volume, ﬂ 8.2  1.2 8.1  1.1 8.0  1.1 0.221
White blood cell count, x 109/L 12.42  3.11 12.17  2.82 12.15  2.97 0.788
Neutrophile count, x 109/L 8.67  2.78 9.42  2.82 10.04  2.97 0.004
Lymphocyte count, x 109/L 2.75  0.96 1.90  0.38 1.34  0.46 <0.001
Neutrophil to lymphocyte ratio 3.44  1.47 5.24  2.20 8.44  3.83 <0.001
Pre-procedural TIMI ﬂow grade
0, n(%)
58 (60.4) 51 (53.1) 60 (63.2) 0.486
Post-procedural TIMI ﬂow grade
3, n (%)
90 (93.8) 86 (89.6) 52 (54.7) <0.001
Post-procedural TIMI ﬂow grade
2, n (%)
6 (6.3) 10 (10.4) 43 (45.3) <0.001
Drug eluting stents, n (%) 39 (40.6) 42 (43.8) 46 (48.4) 0.551
Stent diameter, mm 3.02  0.39 3.01  0.42 2.96  0.36 0.462
Stent length, mm 22.5  5.4 22.5  6.7 24.0  7.3 0.361
Pre-dilatation, n (%) 79 (82.3) 78 (81.3) 80 (84.2) 0.861
Post-dilatation, n (%) 53 (55.2) 55 (57.3) 51 (53.7) 0.881
Non-anterior myocardial
infarction, n (%)
49 (51) 49 (51) 51 (53.7) 0.668
*C-reactive protein levels were available for 175 patients.
Table 1. indicated that there were no statistically signiﬁcant differences
between the study groups with regard to demographic characteristics and
baseline laboratory ﬁndings.
Group I (n¼40) Group II (n¼61) P value
Male (n,%) 21(52) 41(67) 0.10
Age (years) 639 6310 0.95
BMI (kg/m2) 273.0 273.5 0.85
Smoking (n, %) 10(25) 21(34) 0.21
DM (n,%) 18(45) 21(34) 0.19
HT (n,%) 24(60) 29(48) 0.15
Hemoglobin(mg/dl) 13.81.5 13.91.6 0.87
Creatinine (mg/dl) 0.980.24 1.10.31 0.10
Total cholesterol (mg/dl) 198 40 195 37 0.88
LDL cholesterol (mg/dl) 12030 12535 0.48
HDL cholesterol (mg/dl) 418 409 0.75
Triglyceride (mg/dl) 18771 16487 0.28
Hs-CRP(mg/L) 7.82.2 3.61.4 0.001
Table 2. White blood cell, neutrophil, lymphocyte, and monocyte counts of
groups.
Group I
(n¼40)
Group II
(n¼61) P values
Neutrophils,(x1000/ml) 6.5 1.9 5.2 1.4 0.001
Lymphocytes,(x1000/ml) 1.7 0.6 2.50.6 0.001
Neutrophil/lymphocyte ratio 4.1 1.7 2.1 0.9 0.001
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Transcatheter Closure of PDAs at the Seriously Ill premature Babies
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Zatıgül S¸afak Taviloglu, Ercan Sivaslı
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Aım: The aim of this stud was to evaluate our institutional experience of transcatheter
closure of PDA at the seriously ill premature babies. Currently available technology is
not designed for these age groups. Transcatheter occlusion of PDA at the preterm
babies challenges the interventionist.
Methods: Eleven seriously ill premature infants underwent PDA closure with
different devices, if they still had clinically important PDA, despite appropriate
medical treatment. Only venous approach was used in nine patients. The Amplatzer
duct occluder (ADO) type II, Cook detachable coil and ADO type II additional sizes
were used. Co-morbid problems listed like this: respiratory distress syndrome in 9
patients, necrotizing enterocolitis in 7, intracranial hemorrhage in 7, bronchopulmo-
nary dysplasia in 5, extreme prematüre in 4, intravascular coagulopahty in 3, and renal
failure in 2, and pulmonary hemorrhage in 2 patients. All the patients had entubated.
Results: Gestational age of patients was ranged between 26-31 weeks. Mean birth
weight was 1120  260 (900-1610) gr, procedural weight was 1870  510 (1190-
2820) gr. Mean age of the patient was 36 (14 – 90) day. Mean PDA dimension at the
angiography was 2.55 (1–3.5) mm. 4F sheath was used at the all procedures. All
implantations were technically successful. Echocardiography conﬁrmed no residual
shunts on the following day. During manipulation, cardiac perforation occurred in one
patient and the patient was lost. Another patient died six days after procedure because
of co-morbid problems. PDAs were completely occluded without signiﬁcant
obstruction of the pulmonary arteries or aorta. Additional sizes were used in 9 times;
the others were used once.
Conclusıons: At these special age groups, delicate catheter and guidewire manipu-
lation is needed. Especially, the lower proﬁle and symmetry of ADO additional sizes
give the opportunity to close PDAs in premature babies Transcatheter technique is
possible at the seriously ill preterm infants. And it is a safe alternative to surgical
ligation especially for the critically ill patients.C226 JACC VoPP-367
Increased Neutrophile to Lymphocyte Ratio is Related with Poor Coronary
Collateral Development in Patients with Stable Coronary Artery Disease
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Objectıves: The strong relationship between increased neutrophile to lymphocyte
ratio (NRL) and cardiovascular disease has been shown in many studies. In this study,
we investigated whether serum NLR levels affect coronary collateral circulation in
patients with stable coronary artery disease
Methods: The study population consisted of 101 patients who underwent coronary
angiography with a suspicion of coronary artery disease. Blood samples were taken and
NLR levels were analyzed for all patients. Rentrop collateral classiﬁcation was per-
formed. Patients were divided into two groups on the basis of Rentrop scores: group I
consisted of 40 patients (31 male, 16 female) with grade 0-1 collateral development
regarded as poor collateral group and group II consisted of 61 patients (29 male, 14
female) with grade 2-3 collateral development regarded as good collateral group.
Results: Table 1 indicated that there were no statistically signiﬁcant differences
between the study groups with regard to demographic characteristics and baseline
laboratory ﬁndings. Table 2 concluded that Group 1 had signiﬁcantly higher NLR
levels compared with Group 2 (6.51.9 vs. 5.21.4 mg/dl, p¼0.001). Figure 1
showed that NLR levels were higher in patients with absence of coronary collateral
compared with patients with presence of coronary collateral (4.01.7 vs. 2.61.5,
p¼0.001).
Conclusıon: Serum NLR level on admission is associated with poor CCC develop-
ment and may be a useful biomarker for stratiﬁcation of risk in patients with stable
coronary artery disease.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
